Showing results (481-490 of 884) with videos related to
Sort By:
Pageof 89
Inflammatory Bowel Diseases|November 22, 2019
Short Disease Duration Is Associated With Increased Risk of Treatment Failure in Biologic-Treated Patients With Ulcerative ColitisNghia H Nguyen, Soumya Kurnool, Parambir S Dulai, et al.JACC. Case Reports|May 15, 2026
Reverse Takotsubo Syndrome in Women During High Hormonal States Related to In Vitro FertilizationAlexander Y Lee, Siddharth Singh, Paul J Marano, et al.Inflammatory Bowel Diseases|August 19, 2006
Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, MinnesotaTine Jess, Edward V Loftus, Fernando S Velayos, et al.Journal of Crohn'S & Colitis|August 17, 2021
Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised TrialSéverine Vermeire, Geert D'Haens, Filip Baert, et al.Frontiers in Immunology|October 21, 2024
Clinical phenotype, NOD2 genotypes, and treatment observations in Yao syndrome: a retrospective case seriesKatrina A Williamson, Matthew J Samec, Jenny A Patel, et al.Inflammatory Bowel Diseases|March 20, 2021
Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical ProgramBruce E Sands, Millie D Long, Walter Reinisch, et al.Inflammatory Bowel Diseases|July 29, 2009
Assessment of appropriateness of indications for CT enterography in younger patientsLuís S Guimarães, Jeff L Fidler, Joel G Fletcher, et al.Radiology|October 13, 2006
Active Crohn disease: CT findings and interobserver agreement for enteric phase CT enterographyFargol Booya, Joel G Fletcher, James E Huprich, et al.Annals of the New York Academy of Sciences|September 30, 2016
Genome privacy: challenges, technical approaches to mitigate risk, and ethical considerations in the United StatesShuang Wang, Xiaoqian Jiang, Siddharth Singh, et al.The American Journal of Gastroenterology|August 17, 2011
The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safetyGert Van Assche, James D Lewis, Gary R Lichtenstein, et al.Pageof 89